Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $2.72 and traded as low as $2.43. Organicell Regenerative Medicine shares last traded at $2.50, with a volume of 875 shares traded.
Organicell Regenerative Medicine Price Performance
The firm’s fifty day moving average is $2.71 and its two-hundred day moving average is $2.55.
Organicell Regenerative Medicine Company Profile
Biotech Products Services & Research, Inc is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services.
See Also
- Five stocks we like better than Organicell Regenerative Medicine
- Investing In Preferred Stock vs. Common Stock
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Quiet Period Expirations Explained
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Insider Buying Explained: What Investors Need to Know
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
